| Curia Expands Fermentation Capacity in León, Spain | 9 Nov 2026 |
| Curia Invests $28 Million in Sterile API Manufacturing | 5 Oct 2026 |
| Curia Establishes Office of the CEO | 1 Oct 2026 |
| eXoZymes Selects Curia as Commercial-Scale Manufacturing Partner for NCT | 8 Sep 2026 |
| Curia Celebrates Expansion of Albuquerque Facility with Ribbon-Cutting Ceremony | 3 Sep 2026 |
| Curia Global Announces Recapitalization with Its Financial Stakeholders to Support Long-Term Growth | 8 Jul 2026 |
| Curia Completes Upgrade of API Aseptic Suites in Valladolid, Spain | 19 May 2026 |
| Curia Expands Glasgow Manufacturing Capacity and Enhances Cell Line Development Platform | 19 Mar 2026 |
| Curia Receives 2024 CDMO Leadership Award | 19 Mar 2026 |
| Curia Releases 2024 Environmental, Social and Governance (ESG) Report | 28 Oct 2025 |
| Curia Invests $4 Million to Enhance Sterile API Manufacturing | 27 Oct 2025 |
| Curia Sterile Drug Product Facility Named Massachusetts Manufacturer of the Year | 21 Oct 2025 |
| Curia Announces Expansions to Global Network of Sterile Fill-Finish Sites | 17 Mar 2025 |
| Curia Announces Strategic Refinancing to Support Continued Growth | 7 Mar 2025 |
| Curia Commits to SBTi Net-Zero Standard | 11 Oct 2024 |
| Curia Unveils Brand Refresh at CPHI WW in Milan | 9 Oct 2024 |
| Curia and Carterra Partner on Biologics Symposium to Further Biotechnology Research in the Pacific Northwest | 28 Sep 2024 |
| AMRI Appoints Scott Waldman to Lead Corporate Development | 16 Sep 2024 |
| Curia Earns Spot on Forbes America’s Best Employers 2021 List | 16 Sep 2024 |
| AMRI Included in BARDA CDMO Network in Support of COVID-19 Pandemic Response in the U.S. | 16 Sep 2024 |
| Curia Joins Network of Approved Manufacturers of Lipid Excipients for Pfizer-BioNTech COVID-19 Vaccine | 16 Sep 2024 |
| AMRI Leads the Industry in Highest Ranking from SafeBridge for Highly Potent Compound Safety | 16 Sep 2024 |
| AMRI Named Exclusive API Supplier for Recently Approved Acne Treatment | 16 Sep 2024 |
| AMRI Selected to Support AstraZeneca in Delivery of COVID-19 Vaccine | 16 Sep 2024 |
| AMRI Wins 2021 CMO Leadership Awards — Recognized in All Six Performance Categories | 16 Sep 2024 |
| BryoLogyx Announces Agreements with Neurotrope to Acquire Bryostatin-1 Immuno-Oncology Data Package, Supply Synthetic Bryostatin-1 Synthesized by AMRI | 16 Sep 2024 |
| Curia Adds to Accelerated R&D and Manufacturing Solutions for Orphan Products to Treat Rare Diseases | 16 Sep 2024 |
| Curia Adopts the Berkeley Lights Platform to Expand its Antibody Discovery Capabilities | 16 Sep 2024 |
| Curia and Replicate Bioscience Enter Strategic Collaboration to Create Groundbreaking Development Platform for Self-Replicating RNA (srRNA) | 16 Sep 2024 |
| Curia Appoints Philip Macnabb as Chief Executive Officer | 16 Sep 2024 |
| Curia Celebrates Ground-breaking Ceremony in Albuquerque | 16 Sep 2024 |
| Curia Collaborates with Corning to Advance Biopharmaceutical Continuous-Flow Development and Manufacturing Programs | 16 Sep 2024 |
| Curia Completes Acquisition of Integrity Bio: Transaction adds biologic capabilities, expands capacity | 16 Sep 2024 |
| Curia Completes Acquisition of LakePharma | 16 Sep 2024 |
| Curia completes “Center of Speed” expansion with new GMP suites | 16 Sep 2024 |
| Curia Enters Cooperative Agreement with U.S. Government to Expand Sterile Fill-Finish Capability | 16 Sep 2024 |
| Curia expands biologics capabilities with access to Touchlight’s doggybone DNA | 16 Sep 2024 |
| Curia Recognized on Forbes America’s Best Employers 2022 List | 16 Sep 2024 |
| Curia to Acquire Integrity Bio, Expanding Biologic Formulation and Fill-Finish Capabilities | 16 Sep 2024 |
| Curia to Acquire US-Based LakePharma, Expanding End-to-End R&D Capabilities and Scale for Biologics | 16 Sep 2024 |
| Curia to Expand U.S. Commercial Manufacturing Capability | 16 Sep 2024 |
| Curia Unveils Comprehensive mRNA Solution | 16 Sep 2024 |
| Integrity Bio and LakePharma Become Curia | 16 Sep 2024 |
| John Ratliff Named CEO of AMRI | 16 Sep 2024 |
| SafeBridge Consultants Awards AMRI Industry Leader Potent Compound Safety Certification | 16 Sep 2024 |
| Tryp Therapeutics Partners With Albany Molecular Research Inc. To Manufacture a Proprietary Psilobycin-Based Drug | 16 Sep 2024 |
| ViralClear Pharmaceuticals Partners with AMRI on the Manufacture of Merimepodib API in Development for the Potential Treatment of COVID-19 | 16 Sep 2024 |
| Willow Biosciences Announces Cannabinoid Scale-Up and Expedited Path to Commercialization | 16 Sep 2024 |